Connect with us

Politics

Report: VP Harris hired child actors to appear NASA video

Published

on

Screen Shot 2021 10 12 at 3.39.39 PM

Vice President Kamala Harris reportedly hired child actors for a recent NASA video about space. Harris was assigned to lead the Cabinet-level National Space Council in May.

KSBW TV interviewed 13-year-old Trevor Bernardino, who claimed he submitted a recorded monologue talking about something he’s passionate about. In addition, he listed three questions he would ask a world leader. At the time, he did not know the audition included a cameo with the vice president. Then, the director of the production to tested Bernadino’s interviewing skills.

They filmed the video at Harris’ home on August 11-13. At the time, the U.S. was in the middle of withdrawing troops from Afghanistan.

As a result, people on Twitter responded to the news by calling out Harris for being “fake.”

“Just when you thought the most fake human being in the history of the world couldn’t get any more phony there’s this,” Donald Trump Jr. tweeted. “Her commitment to cringe is truly impressive! Kamala Harris hired child actors to be part of her widely-mocked NASA space video.”

https://twitter.com/donaldjtrumpjr/status/1447726866618621952?s=21

Then, Sen. Ted Cruz (R-TX) chimed in. “Wow,” Cruz tweeted. “Even for politics, this is cynical. Quite literally…fake news.”

http://twitter.com/tedcruz/status/1447953702053154819

Next, former Georgia State Director for former President Trump Seth Weathers compared the video to an episode of VEEP. The show is a comedy about the troubles of the first female vice president starring Julia Louise Dreyfus.

http://twitter.com/sethweathers/status/1446816794015150080?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1446816794015150080%7Ctwgr%5E%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Fdailycaller.com%2F2021%2F10%2F11%2Fkamala-harris-space-video-child-actors%2F

The White House told the Daily Mail Tuesday that YouTube chose the children featured.

You can follow Jenny Goldsberry on Twitter @jennyjournalism.

Continue Reading

Healthcare

Supreme Court rules anti-abortion doctors lack standing to sue FDA

Published

on

Supreme Court

In a unanimous decision on Thursday, the Supreme Court ruled that the anti-abortion doctors who challenged the Food and Drug Administration’s (FDA) approval of the abortion pill mifepristone lack the standing to sue the federal agency. This ruling preserves the FDA’s existing approval of the drug.

The opinion, authored by Justice Brett Kavanaugh, emphasized that the plaintiffs presented “several complicated causation theories to connect FDA’s actions to the plaintiffs’ alleged injuries in fact.” However, none of these theories were sufficient to establish Article III standing, which requires a personal stake in the dispute.

National Review reports the lawsuit was filed in November 2022 by the Alliance Defending Freedom (ADF) on behalf of the Alliance for Hippocratic Medicine and four pro-life doctors. The plaintiffs claimed that the FDA had no authority to approve the two-pill chemical-abortion regimen under Subpart H, a federal code section allowing expedited approval for drugs treating “serious or life-threatening illnesses.” They argued that pregnancy is not an illness but a normal physiological state.

The plaintiffs also challenged the FDA’s 2016 and 2021 decisions to relax restrictions on mifepristone, such as increasing the gestational age for its use, reducing required office visits, allowing non-doctors to prescribe the pills, and permitting mail delivery during the COVID-19 pandemic.

Abortion opponents expressed disappointment with the decision. Erin Hawley, a lawyer with ADF, criticized the FDA for allegedly endangering women by allowing the use of mifepristone without in-person medical supervision. Ingrid Skop from the Charlotte Lozier Institute and Katie Daniel from Susan B. Anthony Pro-Life America echoed similar sentiments, stressing their concerns about the safety of mail-order abortion drugs.

President Joe Biden, however, applauded the decision, highlighting the ongoing risks to women’s rights to necessary medical treatment in many states.

Justice Kavanaugh’s opinion stated that the plaintiffs did not demonstrate a direct injury that would force them to participate in abortion procedures against their conscience. He added that concerns about the potential for increased emergency room visits did not justify legal standing.

Kavanaugh noted that doctors and citizens opposed to FDA regulations should seek changes through legislative and executive branches rather than the courts. This decision aligns with a previous lower court ruling that found the legal challenge was filed too late, beyond the statute of limitations.

Earlier this year, U.S. District Judge Matthew Kacsmaryk in Texas ruled in favor of the plaintiffs, suspending the FDA’s approval of mifepristone. This decision was subsequently overturned by the Fifth Circuit Court of Appeals, which restored access to the drug. The Supreme Court’s stay ensured that the drug remained available while legal proceedings continued.

Democratic lawmakers welcomed the Supreme Court’s ruling. Congresswoman Ayanna Pressley described it as a “major relief & victory for anyone who has ever or will ever need essential medication abortion care.” Senator Elizabeth Warren criticized the challenge as baseless and underscored the safety and effectiveness of chemical-abortion pills. She warned of ongoing efforts by Republicans to impose a nationwide abortion ban and called for continued protection of reproductive freedom.

 

Continue Reading

Trending